Fifth Third Bancorp
EDSA icon

Fifth Third Bancorp’s Edesa Biotech EDSA Stock Holding History

Fifth Third Bancorp’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$247 – 2661
2025
Q3 		$247 Hold
100
– – ﹤0.01% 2628
2025
Q2 		$203 Hold
100
– – ﹤0.01% 2531
2025
Q1 		$244 Hold
100
– – ﹤0.01% 2490
2024
Q4 		$168 Hold
100
– – ﹤0.01% 2492
2024
Q3 		$445 Hold
100
– – ﹤0.01% 2508
2024
Q2 		$428 Hold
100
– – ﹤0.01% 2391
2024
Q1 		$419 Hold
100
– – ﹤0.01% 2321
2023
Q4 		$457 Hold
100
– – ﹤0.01% 2453
2023
Q3 		$442 Hold
100
– – ﹤0.01% 2517
2023
Q2 		$568 Hold
100
– – ﹤0.01% 2548
2023
Q1 		$638 Hold
100
– – ﹤0.01% 2686
2022
Q4 		$1.51K Hold
100
– – ﹤0.01% 2475
2022
Q3 		$1K Hold
100
– – ﹤0.01% 2539
2022
Q2 		$1K Hold
100
– – ﹤0.01% 2520
2022
Q1 		$2K Hold
100
– – ﹤0.01% 2519
2021
Q4 		$4K Hold
100
– – ﹤0.01% 2396
2021
Q3 		$5K Hold
100
– – ﹤0.01% 2196
2021
Q2 		$4K Hold
100
– – ﹤0.01% 2235
2021
Q1 		$4K Buy
+100
New +$4.03K ﹤0.01% 2215

Other funds holding EDSA

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's EDSA Position: Q4 2025 in Review

Fifth Third Bancorp sold out of Edesa Biotech (EDSA) in Q4 2025, closing a stake of 100 shares — an estimated $247 sold.

Fifth Third Bancorp first reported a position in EDSA in Q1 2021 and held it in 19 quarters. The position peaked at $5K in Q3 2021. 22 funds tracked by Wall St. Rank hold EDSA as of Q4 2025.

  • Fifth Third Bancorp reported no remaining Edesa Biotech position as of Q4 2025 after selling out during the quarter.
  • Fifth Third Bancorp sold 100 Edesa Biotech shares in Q4 2025, an estimated $247.
  • Fifth Third Bancorp first reported a position in Edesa Biotech in Q1 2021 and held it in 19 quarters.
  • Fifth Third Bancorp's Edesa Biotech position peaked at $5K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2025.

Based on Fifth Third Bancorp's 13F filing for Q4 2025, filed 2 Feb 2026.